VANCOMYCIN AUC: MIC VERSUS TROUGH MONITORING IN PATIENTS RECEIVING CRRT

被引:0
|
作者
Martens, Mycah [1 ]
Nixon, Alexander [2 ]
Cooper-Johnson, Kaitlin [3 ]
Juul, Janelle [4 ]
Herrmann, David [1 ]
Tchen, Stephanie [1 ]
Feih, Joel [3 ]
机构
[1] Froedtert Hosp, Wauwatosa, WI USA
[2] Miami Valley Hosp, Milwaukee, WI USA
[3] Froedtert & Med Coll Wisconsin, Froedtert Hosp, Milwaukee, WI USA
[4] Froedtert Lutheran Mem Hosp, MILWAUKEE, WI USA
关键词
D O I
10.1097/01.ccm.0001102580.41699.3a
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] VANCOMYCIN IN CRITICALLY ILL PATIENTS RECEIVING CRRT AND ASSESSMENT OF A PHARMACY-TO-DOSE PROTOCOL
    Doolin, Meagan
    Fritschle, Andrew
    Harris, Serena
    Erdman, Sharon
    Fleming, Megan
    Foster, David
    Walroth, Todd
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [42] A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
    Katip, Wasan
    Oberdorfer, Peninnah
    PHARMACEUTICS, 2021, 13 (09)
  • [43] The usefulness of proactive monitoring in hospitalized patients receiving vancomycin
    Raffo Nogueira, Juan B.
    Dodero Anillo, Jose Manuel
    Hidalgo Rios, Samuel
    Pedrosa Martinez, Maria Jose
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 35 - 36
  • [44] Cost-benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin
    Lee, Brian, V
    Fong, Gary
    Bolaris, Michael
    Neely, Michael
    Minejima, Emi
    Kang, Amy
    Lee, Grace
    Gong, Cynthia L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1346.e1 - 1346.e7
  • [45] APPLICATION OF PHARMACODYNAMIC PRINCIPLES (AUC/MIC) TO IMPROVE CLINICAL EFFICACY IN INDIVIDUAL TREATMENT WITH VANCOMYCIN
    Rodriguez-Jimenez, C.
    Garcia-Saiz, M.
    Munoz-Cortes, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 22 - 23
  • [46] Application of pharmacokinetic and pharmacodynamic principles (AUC/MIC) to individualize treatment with vancomycin in neonatal population
    Masiero Aparicio, Paula Belen
    Rodriguez Jimenez, Consuelo Maria
    Garcia Saiz, Maria del Mar
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 33 - 33
  • [47] Comment: Outcomes Associated with AUC24/MIC Nomogram Dosing of Vancomycin REPLY
    Michalets, Elizabeth Landrum
    Pounders, Cristy L.
    Hollis, Sarah J.
    Sutherland, Susan
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (10) : 1314 - 1315
  • [48] APPLICATION OF PHARMACODYNAMIC PRINCIPLES (AUC/MIC) TO IMPROVE THE CLINICAL EFFICACY OF INDIVIDUALIZED TREATMENT WITH VANCOMYCIN
    Rodriguez Jimenez, C.
    Garcia Saiz, M. M.
    Herrera Herrera, J.
    Masiero Aparicio, P.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E132 - E132
  • [49] Evaluation of the Association between Trough and Area Under the Curve to Minimum Inhibitory Concentration Ratio (AUC24/MIC) of Vancomycin in Infected Patients with Methicillin Resistant Staphylococcus aureus (MRSA)
    Esmaeili, Ayda
    Salehi, Mohammadreza
    Makhdomi, Nava
    Ardakani, Yalda H.
    Rajabi, Mehdi
    Namazi, Soha
    PHARMACEUTICAL SCIENCES, 2021, 27 (02) : 201 - 208
  • [50] Vancomycin 10 Mg/Kg Twice Daily Dosing for Critically Ill Patients Receiving Crrt
    Willenborg, Matthew
    Moore, Daniel
    Peppard, William
    Schulz, Lucas
    Fish, Jeffrey
    CRITICAL CARE MEDICINE, 2013, 41 (12)